PENGEMBANGAN INSTRUMEN PENILAIAN SELF AND PEER ASSESSMENT PADA KOMPETENSI DASAR MELAKSANAKAN PRODUKSI HASIL SUSU

Penelitian ini bertujuan untuk mengembangkan instrumen self and peer assessment untuk menilai kinerja siswa SMK pada praktikum melaksanakan produksi hasil hewani. Pada penelitian yang dilakukan yaitu dengan tiga tahap uji coba skala kecil, uji coba skala besar, dan tahap implementasi produk yang dilakukan kepada siswa SMK kelas XI TPHP 2 dan XI TPHP 3. Subjek penelitian untuk uji coba skala kecil sebanyak 10 orang, tahap uji coba skala besar 20 orang, dan tahap implementasi sebanyak 30 orang. Penelitian ini menggunakan metode Penelitian dan Pengembangan Research and Development (R&D). Sebelum penilaian kinerja self and peer assessment diaplikasikan kepada siswa, dilakukan uji kelayakan oleh judgement ahli, dari hasil penelitian menunjukan hasil validasi oleh penilaian ahli materi memiliki tingkat ketercapaian sangat layak. Dari 16 indikator yang digunakan, 14 indikator dinyatakan sangat layak, sedangkan 2 indikator lainnya dinyatakan layak sehingga dapat dilakukan pengujian selanjutnya. Pada hasil ketercapaian pelaksaanan self and peer-assessment, tahap pemberian motivasi, pelatihan self and peer assessment, pelaksanaan self and peer assessment, pengkomunikasian hasil dan pemberian feedback yaitu memperoleh rata-rata hasil uji skala kecil 82%, skala besar 91,4% dan tahap implementasi 92,4%. Kemampuan siswa dalam melakukan self and peer assessment tergolong kategori “sangat baik” dengan penilaian hasil perbandingan antara self-assessment dan observer dari 30 siswa sebanyak 22 siswa melakukan penilaian yang sama dengan observer dan peer assessment, sebanyak 26 siswa dari 30 siswa melakukan penilaian yang sama dengan observer. Penilaian afektif siswa berdasarkan dalam menggunakan instrumen self and peer assessment mampu menumbuhkan dan mempertahankan sikap spiritual dan sosial yang baik pada proses pembelajaran. ;---This study aims to develop self and peer assessment instruments to assess the performance of vocational high school students on practicum in the production of animal products. In the research conducted through three stages of small-scale testing, large-scale testing, and product implementation stages, conducted to vocational high school students class XI TPHP 2 and XI TPHP 3. Research subjects for small-scale testing of 10 people, large-scale testing of 20 people, and implementation stage of 30 people. This research uses Research and Development (R&D) method. Before the self and peer assessment performance was applied to the student, feasibility test were performed by judgment expert, from the results of the study showed the validation results by the assessment of material experts have a very feasible level of achievement. Of the 16 indicators used, there are 14 indicators stated very feasible, while the other 2 indicators declared feasible hence further testing can be done. In the achievement of self and peer-assessment, motivation stage, self and peer assessment training, self and peer assessment performance, communicating result and giving feedback, obtains the average result of small scale test of 82%, large scale 91,4% and implementation stage 92.4%. The students' ability to conduct self and peer-assessment is categorized as "excellent" with the result of comparison between self-assessment and observer from 30 students, 22 students do the same assessment as the observer and peer assessment. 26 students from 30 students did the same assessment as the observer. Students' affective assessment based on using peer and self-assessment instruments can foster and maintain good spiritual and social attitudes in the learning process

A z=0 Multi-wavelength Galaxy Synthesis I: A WISE and GALEX Atlas of Local Galaxies

We present an atlas of ultraviolet and infrared images of ~15,750 local (d < 50 Mpc) galaxies, as observed by NASA's WISE and GALEX missions. These maps have matched resolution (FWHM 7.5'' and 15''), matched astrometry, and a common procedure for background removal. We demonstrate that they agree well with resolved intensity measurements and integrated photometry from previous surveys. This atlas represents the first part of a program (the z=0 Multi-wavelength Galaxy Synthesis) to create a large, uniform database of resolved measurements of gas and dust in nearby galaxies. The images and associated catalogs are publicly available at the NASA/IPAC Infrared Science Archive. This atlas allows us estimate local and integrated star formation rates (SFRs) and stellar masses (M$_\star$) across the local galaxy population in a uniform way. In the appendix, we use the population synthesis fits of Salim et al. (2016, 2018) to calibrate integrated M$_\star$ and SFR estimators based on GALEX and WISE. Because they leverage an SDSS-base training set of >100,000 galaxies, these calibrations have high precision and allow us to rigorously compare local galaxies to Sloan Digital Sky Survey results. We provide these SFR and M$_\star$ estimates for all galaxies in our sample and show that our results yield a "main sequence" of star forming galaxies comparable to previous work. We also show the distribution of intensities from resolved galaxies in NUV-to-WISE1 vs. WISE1-to-WISE3 space, which captures much of the key physics accessed by these bands.Comment: 46 pages, 27 figures, published in ApJS (https://ui.adsabs.harvard.edu/abs/2019ApJS..244...24L/abstract ). See that version for full resolution figures and machine readable tables. Go download data for your favorite nearby galaxy here: https://irsa.ipac.caltech.edu/data/WISE/z0MGS/overview.html . The appendix presents detailed analysis of translations to physical quantitie

Creating testable questions in practical conservation:a process and 100 questions

It is now clear that the routine embedding of experiments into conservation practice is essential for creating reasonably comprehensive evidence of the effectiveness of actions. However, an important barrier is the stage of identifying testable questions that are both useful but also realistic to carry out without a major research project. We identified approaches for generating such suitable questions. A team of 24 participants crowdsourced suggestions, resulting in a list of a hundred possible tests of actions.</p

The lifecycle of molecular clouds in nearby star-forming disc galaxies

It remains a major challenge to derive a theory of cloud-scale (⁠≲100 pc) star formation and feedback, describing how galaxies convert gas into stars as a function of the galactic environment. Progress has been hampered by a lack of robust empirical constraints on the giant molecular cloud (GMC) lifecycle. We address this problem by systematically applying a new statistical method for measuring the evolutionary timeline of the GMC lifecycle, star formation, and feedback to a sample of nine nearby disc galaxies, observed as part of the PHANGS-ALMA survey. We measure the spatially resolved (∼100 pc) CO-to-H α flux ratio and find a universal de-correlation between molecular gas and young stars on GMC scales, allowing us to quantify the underlying evolutionary timeline. GMC lifetimes are short, typically 10−30 Myr⁠, and exhibit environmental variation, between and within galaxies. At kpc-scale molecular gas surface densities Σ_(H₂) ≥ 8 M_⊙ pc⁻²⁠, the GMC lifetime correlates with time-scales for galactic dynamical processes, whereas at Σ_(H₂) ≤ 8 M_⊙ pc⁻² GMCs decouple from galactic dynamics and live for an internal dynamical time-scale. After a long inert phase without massive star formation traced by H α (75–90 per cent of the cloud lifetime), GMCs disperse within just 1−5 Myr once massive stars emerge. The dispersal is most likely due to early stellar feedback, causing GMCs to achieve integrated star formation efficiencies of 4–10 per cent. These results show that galactic star formation is governed by cloud-scale, environmentally dependent, dynamical processes driving rapid evolutionary cycling. GMCs and H II regions are the fundamental units undergoing these lifecycles, with mean separations of 100−300 pc in star-forming discs. Future work should characterize the multiscale physics and mass flows driving these lifecycles

Creating testable questions in practical conservation: a process and 100 questions

It is now clear that the routine embedding of experiments into conservation practice is essential for creating reasonably comprehensive evidence of the effectiveness of actions. However, an important barrier is the stage of identifying testable questions that are both useful but also realistic to carry out without a major research project. We identified approaches for generating such suitable questions. A team of 24 participants crowdsourced suggestions, resulting in a list of a hundred possible tests of actions

Medical Crises in Older People: cohort study of older people attending acute medical units, developmental work and randomised controlled trial of a specialist geriatric medical intervention for high-risk older people; cohort study of older people with mental health problems admitted to hospital, developmental work and randomised controlled trial of a specialist medical and mental health unit for general hospital patients with delirium and dementia; and cohort study of residents of care homes and interview study of health-care provision to residents of care homes

BackgroundThis programme of research addressed shortcomings in the care of three groups of older patients: patients discharged from acute medical units (AMUs), patients with dementia and delirium admitted to general hospitals, and care home residents.MethodsIn the AMU workstream we undertook literature reviews, performed a cohort study of older people discharged from AMU (Acute Medical Unit Outcome Study; AMOS), developed an intervention (interface geriatricians) and evaluated the intervention in a randomised controlled trial (Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study; AMIGOS). In the second workstream we undertook a cohort study of older people with mental health problems in a general hospital, developed a specialist unit to care for them and tested the unit in a randomised controlled trial (Trial of an Elderly Acute care Medical and mental health unit; TEAM). In the third workstream we undertook a literature review, a cohort study of a representative sample of care home residents and a qualitative study of the delivery of health care to care home residents.ResultsAlthough 222 of the 433 (51%) patients recruited to the AMIGOS study were vulnerable enough to be readmitted within 3 months, the trial showed no clinical benefit of interface geriatricians over usual care and they were not cost-effective. The TEAM study recruited 600 patients and there were no significant benefits of the specialist unit over usual care in terms of mortality, institutionalisation, mental or functional outcomes, or length of hospital stay, but there were significant benefits in terms of patient experience and carer satisfaction with care. The medical and mental health unit was cost-effective. The care home workstream found that the organisation of health care for residents in the UK was variable, leaving many residents, whose health needs are complex and unpredictable, at risk of poor health care. The variability of health care was explained by the variability in the types and sizes of homes, the training of care home staff, the relationships between care home staff and the primary care doctors and the organisation of care and training among primary care doctors.DiscussionThe interface geriatrician intervention was not sufficient to alter clinical outcomes and this might be because it was not multidisciplinary and well integrated across the secondary care–primary care interface. The development and evaluation of multidisciplinary and better-integrated models of care is justified. The specialist unit improved the quality of experience of patients with delirium and dementia in general hospitals. Despite the need for investment to develop such a unit, the unit was cost-effective. Such units provide a model of care for patients with dementia and delirium in general hospitals that requires replication. The health status of, and delivery of health care to, care home residents is now well understood. Models of care that follow the principles of comprehensive geriatric assessment would seem to be required, but in the UK these must be sufficient to take account of the current provision of primary health care and must recognise the importance of the care home staff in the identification of health-care needs and the delivery of much of that care.Trial registrationCurrent Controlled Trials ISRCTN21800480 (AMIGOS); ClinicalTrials.gov NCT01136148 (TEAM)

Creating testable questions in practical conservation: a process and 100 questions

It is now clear that the routine embedding of experiments into conservation practice is essential for creating reasonably comprehensive evidence of the effectiveness of actions. However, an important barrier is the stage of identifying testable questions that are both useful but also realistic to carry out without a major research project. We identified approaches for generating such suitable questions. A team of 24 participants crowdsourced suggestions, resulting in a list of a hundred possible tests of actions.Additional co-authors: Roger Mitchell, William H. Morgan, Roy Mosley, Silviu O. Petrovan, Kit Prendergast, Euan G. Ritchie, Hugh Raven, Rebecca K. Smith & Ann Thornto

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Background Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. Methods In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. Findings Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18–45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference −1·4%, 95% CI −7·0 to 4·3; hazard ratio 0·96, 0·68–1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3–4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). Interpretation Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707